# FDA 483 - Jatin Vadhvana, M.B.B.S. - March 31, 2023

Source: https://www.globalkeysolutions.net/records/483/jatin-vadhvana-mbbs/f6087651-a41a-4021-a0f3-5fb535da72d3

> FDA 483 for Jatin Vadhvana, M.B.B.S. on March 31, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Jatin Vadhvana, M.B.B.S.
- Inspection Date: 2023-03-31
- Product Type: drugs
- Office Name: Center for Veterinary Medicine
- Summary: An FDA inspection of Jatin Vadhvana, M.B.B.S. in Ahmedabad, Gujarat, India, a clinical investigator, revealed deficiencies in informed consent procedures. The firm failed to ensure prospective subjects had sufficient opportunity to consider participation and minimized coercion or undue influence. Specifically, illiterate subjects were enrolled using compensated impartial witnesses who routinely provided this service.

## Related Officers

- [Phuc L Nguyen](https://www.globalkeysolutions.net/people/phuc-l-nguyen/a09d01df-4588-4062-9b28-4bb2a66ce968)
- [Investigator](https://www.globalkeysolutions.net/people/lori-gioia/34b9339b-0bd2-4e41-8da1-b445ad829e53)

Company: https://www.globalkeysolutions.net/companies/jatin-vadhvana-mbbs/557e70f8-a58b-4898-98ae-8feae28674e9

Office: https://www.globalkeysolutions.net/offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4